On Monday, Idexx Laboratories, Inc (NASDAQ: IDXX) was 3.44% up from the session before settling in for the closing price of $435.69. A 52-week range for IDXX has been $398.50 – $583.39.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 10.69%. When this article was written, the company’s average yearly earnings per share was at 3.94%. With a float of $81.08 million, this company’s outstanding shares have now reached $82.04 million.
Considering the fact that the conglomerate employs 11000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 60.76%, operating margin of 28.97%, and the pretax margin is 28.43%.
Idexx Laboratories, Inc (IDXX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Idexx Laboratories, Inc stocks. The insider ownership of Idexx Laboratories, Inc is 0.99%, while institutional ownership is 91.23%. The most recent insider transaction that took place on Nov 27 ’24, was worth 144,630. In this transaction Director of this company sold 344 shares at a rate of $420.44, taking the stock ownership to the 905 shares. Before that another transaction happened on Nov 27 ’24, when Company’s Director proposed sale 344 for $420.44, making the entire transaction worth $144,630.
Idexx Laboratories, Inc (IDXX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 3.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.00% during the next five years compared to 18.76% growth over the previous five years of trading.
Idexx Laboratories, Inc (NASDAQ: IDXX) Trading Performance Indicators
You can see what Idexx Laboratories, Inc (IDXX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.78. Likewise, its price to free cash flow for the trailing twelve months is 47.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 10.36, a number that is poised to hit 2.40 in the next quarter and is forecasted to reach 11.98 in one year’s time.
Technical Analysis of Idexx Laboratories, Inc (IDXX)
Compared to the last year’s volume of 0.51 million, its volume of 0.78 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 79.72%. Additionally, its Average True Range was 11.41.
During the past 100 days, Idexx Laboratories, Inc’s (IDXX) raw stochastic average was set at 39.50%, which indicates a significant decrease from 95.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.05% in the past 14 days, which was lower than the 27.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $445.03, while its 200-day Moving Average is $488.21. Nevertheless, the first resistance level for the watch stands at $456.62 in the near term. At $462.57, the stock is likely to face the second major resistance level. The third major resistance level sits at $471.87. If the price goes on to break the first support level at $441.37, it is likely to go to the next support level at $432.07. Now, if the price goes above the second support level, the third support stands at $426.12.
Idexx Laboratories, Inc (NASDAQ: IDXX) Key Stats
There are 81,885K outstanding shares of the company, which has a market capitalization of 37.61 billion. As of now, sales total 3,661 M while income totals 845,040 K. Its latest quarter income was 975,540 K while its last quarter net income were 232,840 K.
